Chardan Cuts Price Target on Achilles Therapeutics to $17 From $20, Affirms Buy Rating -December 07, 2022 at 06:40 am| MarketScreener
Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation - Simply Wall St News
What Type Of Shareholders Own The Most Number of Achilles Therapeutics plc (NASDAQ:ACHL) Shares? | Nasdaq
![Achilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights | News | News and insights | Syncona Achilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights | News | News and insights | Syncona](https://www.synconaltd.com/media/bczf0c1p/14-05-18syncona_0426_achilles.jpg?anchor=center&mode=crop&width=954&height=636&rnd=132658910540630000)